Please assess the completion status of the following clinical trial:

Trial Title: The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Written, voluntary, informed consent given~* 18 years or older~* Speak and read English~* Extensive ulcerative colitis based upon endoscopy, histopathology, and clinical symptoms~* SCCAI Score \> 3~* Presence of diarrhea (3 or more bowel movements per 24 hours) AND grossly visible blood in stool~Exclusion Criteria:~* Serum creatinine \> 2.0 mg/dL~* Pregnant or breastfeeding~* Prior history of total or subtotal colectomy, or currently has an ostomy~* History or suspicion of Crohn's disease or Indeterminate colitis~* Diagnosis of any condition deemed by the investigator inhibiting completion of the trial~* Initiated therapy with or change in mesalamine dose within the last 4 weeks~* Change in azathioprine, 6-mercaptopurine, or cyclosporine within the last 8 weeks~* Currently taking or have used corticosteroids within the last 8 weeks~* Rectally administered mesalamine or steroids within the last 2 weeks~* Current or prior use of anti-TNF alpha agents within the last 8 weeks~* Experimental ulcerative colitis agents within the last 8 weeks~* Concomitant use of CYP3A4 activity inhibitor (e.g. ketoconazole, itraconazole, ritonavir, indinavir, erythromycin)~* Uncontrolled diabetes (HgA1c \> 8.0) within 1 year~* Unstable Coronary artery disease/Class III/IV CHF~* Decompensated cirrhosis (e.g. encephalopathy, renal failure, ascites, GIB)~* Any known infection requiring antibiotics~* Active Clostridium difficile infection~* COPD requiring home oxygen~* HIV/AIDS with CD4 \< 200 or AIDs-defining illnesses/infections

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Combination Oral Budesonide and Rectal Hydrocortisone (Type: EXPERIMENTAL): See intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).